HOLLY HNETYNKA: Open Payments
NPI 1114703634 · SHEPHERD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $211 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Viatris Specialty LLC | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| ABBVIE INC. | 2 | $30 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: REXULTI, YUPELRI, BREZTRI, Kerendia, UBRELVY, AIRSUPRA, FARXIGA, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
